{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:57:52Z","timestamp":1790074672938,"version":"4.0.1"},"reference-count":40,"publisher":"Cambridge University Press (CUP)","issue":"6","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Pall Supp Care"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S1478951524000117_sec1a\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>There is concern that hydroxyzine exacerbates delirium, but a recent preliminary study suggested that the combination of haloperidol and hydroxyzine was effective against delirium. This study examined whether the concomitant use of hydroxyzine and haloperidol worsened delirium in patients with cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S1478951524000117_sec2b\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective, observational study was conducted at 2 general hospitals in Japan. The medical records of patients with cancer who received haloperidol for delirium from July to December 2020 were reviewed. The treatments for delirium included haloperidol alone or haloperidol combined with hydroxyzine. The primary outcome was the duration from the first day of haloperidol administration to the resolution of delirium, defined as its absence for 2 consecutive days. The time to delirium resolution was analyzed to compare the haloperidol group and hydroxyzine combination group using the log-rank test with the Kaplan\u2013Meier method. Secondary outcomes were (1) the total dose of antipsychotic medications, including those other than haloperidol (measured in chlorpromazine-equivalent doses), and (2) the frequencies of detrimental incidents during delirium, specifically falls and self-removal of drip infusion lines. The unpaired\n                      <jats:italic>t<\/jats:italic>\n                      -test and Fisher\u2019s exact test were used to analyze secondary outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S1478951524000117_sec3c\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 497 patients who received haloperidol, 118 (23.7%) also received hydroxyzine. No significant difference in time to delirium resolution was found between the haloperidol group and the hydroxyzine combination group (log-rank test,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.631). No significant difference between groups was found in either chlorpromazine-equivalent doses or the frequency of detrimental incidents.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S1478951524000117_sec4d\">\n                    <jats:title>Significance of results<\/jats:title>\n                    <jats:p>This study showed that the concomitant use of hydroxyzine and haloperidol did not worsen delirium in patients with cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/s1478951524000117","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T01:54:36Z","timestamp":1708998876000},"page":"1817-1824","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":2,"title":["Concomitant use of hydroxyzine and haloperidol did not worsen delirium in patients with cancer: A multicenter, retrospective, observational study"],"prefix":"10.1017","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1764-1763","authenticated-orcid":false,"given":"Takatoshi","family":"Hirayama","sequence":"first","affiliation":[{"name":"National Cancer Center Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Igarashi","sequence":"additional","affiliation":[{"name":"Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saho","family":"Wada","sequence":"additional","affiliation":[{"name":"National Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Sadahiro","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanae","family":"Oshikiri","sequence":"additional","affiliation":[{"name":"Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Suzuka","sequence":"additional","affiliation":[{"name":"Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Sato","sequence":"additional","affiliation":[{"name":"Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Utsumi","sequence":"additional","affiliation":[{"name":"Tohoku University Graduate School of Medicine"},{"name":"Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sakuma","sequence":"additional","affiliation":[{"name":"Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Nakahara","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Imai","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Tomita","sequence":"additional","affiliation":[{"name":"Tohoku University Graduate School of Medicine"},{"name":"Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7276-1971","authenticated-orcid":false,"given":"Hiromichi","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"key":"S1478951524000117_ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2022.03.005"},{"key":"S1478951524000117_ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.595584"},{"key":"S1478951524000117_ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2012.02346.x"},{"key":"S1478951524000117_ref5","doi-asserted-by":"publisher","DOI":"10.3109\/00048674.2011.543411"},{"key":"S1478951524000117_ref17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006815.pub2"},{"key":"S1478951524000117_ref28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2210-5-8"},{"key":"S1478951524000117_ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e977"},{"key":"S1478951524000117_ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15767"},{"key":"S1478951524000117_ref15","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-11-200706050-00006"},{"key":"S1478951524000117_ref25","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2014.147"},{"key":"S1478951524000117_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-5198(19)43508-7"},{"key":"S1478951524000117_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2018.02.001"},{"key":"S1478951524000117_ref18","first-page":"675","article-title":"Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies","volume":"25","author":"Haraguchi","year":"1997","journal-title":"Drug Metabolism and Disposition"},{"key":"S1478951524000117_ref21","doi-asserted-by":"publisher","DOI":"10.1111\/jan.14482"},{"key":"S1478951524000117_ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-022-06903-z"},{"key":"S1478951524000117_ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afq140"},{"key":"S1478951524000117_ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430050035004"},{"key":"S1478951524000117_ref9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24215"},{"key":"S1478951524000117_ref35","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afl005"},{"key":"S1478951524000117_ref22","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-311049"},{"key":"S1478951524000117_ref30","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyaa003"},{"key":"S1478951524000117_ref4","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201901-024OC"},{"key":"S1478951524000117_ref34","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.061250"},{"key":"S1478951524000117_ref11","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003299"},{"key":"S1478951524000117_ref36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.01028.x"},{"key":"S1478951524000117_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60688-1"},{"key":"S1478951524000117_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.07.009"},{"key":"S1478951524000117_ref38","unstructured":"Trzepacz, PT , Maldonado, JR , Kean, J , et al. (2009). The Delirium Rating Scale Revised-98 (DRS-R98) administration manual. A guide to increase understanding of how to solicit delirium symptoms to administer the DRS-R98. Indianapolis, IN: Trzepacz."},{"key":"S1478951524000117_ref16","first-page":"83","article-title":"Catecholamine toxicity: A proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson\u2019s disease","volume":"5","author":"Graham","year":"1984","journal-title":"Neurotoxicology"},{"key":"S1478951524000117_ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.8784"},{"key":"S1478951524000117_ref31","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2007.0016"},{"key":"S1478951524000117_ref8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.43.3.175"},{"key":"S1478951524000117_ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2010.05.006"},{"key":"S1478951524000117_ref3","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5\u2122","year":"2013"},{"key":"S1478951524000117_ref32","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704982"},{"key":"S1478951524000117_ref26","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.6.786"},{"key":"S1478951524000117_ref39","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyv100"},{"key":"S1478951524000117_ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-018-0569-8"},{"key":"S1478951524000117_ref7","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.43.3.183"},{"key":"S1478951524000117_ref29","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1112"}],"container-title":["Palliative and Supportive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1478951524000117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:06:49Z","timestamp":1777471609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1478951524000117\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1478951524000117"],"URL":"https:\/\/doi.org\/10.1017\/s1478951524000117","relation":{},"ISSN":["1478-9515","1478-9523"],"issn-type":[{"value":"1478-9515","type":"print"},{"value":"1478-9523","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,27]]},"assertion":[{"value":"\u00a9 The Author(s), 2024. Published by Cambridge University Press.","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}